<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Our data indicates that approximately one-third of PWID participants have serological evidence of HIV (44.9%), HBV (32.8%) or HCV (38.3%), which is substantially higher than prevalence rates estimated for PWID reported from sub-Saharan African region for the three infections at 18.3, 3.7, 21.8%, respectively [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
